HIV感染者破伤风血清保护状况:血清阴性危险因素、病史评估与快速试纸检测
本研究在比利时HIV感染者队列中调查破伤风类毒素血清阴性率及危险因素,并评估疫苗史和快速试纸(TQS)与ELISA相比的性能。
要点
- 疫苗史与血清保护相关性低(kappa=0.09),不适用于筛查。
- TQS快速试纸与ELISA相关性较好(kappa=0.61),可考虑用于筛查。
核心结论
- 在该HIV感染者队列中,社会人口学和教育因素与破伤风类毒素血清阴性相关,而HIV相关因素不相关。
- 疫苗史不可靠,TQS快速试纸可作为筛查破伤风血清阴性的有效工具。
研究设计与样本
- 破伤风类毒素抗体水平≥0.15 IU/mL视为有保护性,部分受试者进行TQS快速试纸检测。
主要发现
- 多因素分析显示,教育水平为中学或以下以及出生在欧洲以外与破伤风类毒素血清阴性独立相关。
- 疫苗史与血清保护相关性低(kappa系数=0.09),疫苗史灵敏度43.8%、特异度76.5%、阳性预测值91.4%、阴性预测值19.3%。
- TQS与血清保护相关性较好(kappa系数=0.61),TQS灵敏度86.4%、特异度96.0%、阳性预测值99.3%、阴性预测值52.17%。
关键数值与推荐
- 破伤风类毒素抗体水平≥0.15 IU/mL定义为有保护性。
- 疫苗史灵敏度43.8%、特异度76.5%、阳性预测值91.4%、阴性预测值19.3%,与血清保护kappa系数=0.09。
- TQS灵敏度86.4%、特异度96.0%、阳性预测值99.3%、阴性预测值52.17%,与血清保护kappa系数=0.61。
临床怎么用
- 对于HIV感染者,尤其是教育水平较低和出生在欧洲以外的移民人群,应关注破伤风血清阴性风险。
- 疫苗信息应针对文化和教育背景进行定制。
- 疫苗史不可靠,可考虑使用TQS快速试纸筛查破伤风血清阴性。
局限性
- TQS检测仅在有限数量的受试者中进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Tetanus is a vaccine-preventable disease. Booster immunization is required in order to induce long-lived tetanus-toxoid (TT) specific antibody response. We investigated the prevalence and risk factors of TT seronegativity in a cohort of people living with HIV (PWH) in Belgium along with the respective performance of vaccine history and a rapid dipstick test (Tetanus Quick Stick ® or TQS) compared to ELISA testing. METHODS: PWH were prospectively enrolled and answered a questionnaire. ELISA was performed on serum or plasma using a commercial kit. A TT antibody level ≥ 0.15 IU / mL was considered protective. The TQS test was performed on a limited number of subjects. RESULTS: Three-hundred forty-four subjects were included. The prevalence of tetanus seroprotection was 84,9%. Median age was 46.7 and 68% were born outside Belgium. Antiretroviral therapy coverage was almost universal (98.5%). After multivariable analysis, two risk factors were independently associated with TT seronegativity: an education level equivalent or below than secondary school and being born outside Europe. Vaccine history was shown to be unreliable (sensitivity: 43.8%; specificity: 76.5%; positive predictive value: 91.4% and negative predictive value :19.3%). The correlation between vaccine history and tetanus seroprotection was low (kappa coefficient = 0.09). The TQS performances were good (sensitivity 86.4%, specificity 96.0%, positive predictive value 99.3%, negative predictive value 52.17%). The correlation between TQS and tetanus seroprotection was substantial (kappa coefficient = 0.61). CONCLUSIONS: In this cohort of PWH with a high proportion of migrants, socio-demographic and educational factors were associated with TT seronegativity while HIV-related factors were not, indicating that vaccine information should be tailored to cultural and educational background. As vaccine history is not reliable, TQS could represent an efficient tool for screening of TT-seronegativity.
引用
- Gobert C, Van Hauwermeiren C, Quoidbach C, et al. Tetanus seroprotection in people living with HIV: Risk factors for seronegativity, evaluation of medical history and a rapid dipstick test. Vaccine. 2021. PMID: 33715902. doi:10.1016/j.vaccine.2021.02.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。